Attorneys Want $3M Fee In Skelaxin Antitrust Row
Attorneys for end-payor plaintiffs accusing Mutual Pharmaceutical Co. Inc. of colluding with King Pharmaceuticals Inc. to delay generic versions of the muscle relaxant Skelaxin asked a Tennessee federal court to grant...To view the full article, register now.
Already a subscriber? Click here to view full article